ANNALS OF TRANSPLANTATION, vol.24, pp.412-417, 2019 (SCI-Expanded)
Background: Cytomegalovirus (CMV) and BK virus (BKV) are post-transplant opportunistic viral infections that affect patient and graft survival. This study was designed to evaluate the risk of BKV nephropathy and CMV disease in kidney transplant recipients who received induction therapy with ATG or basiliximab.